Prognostic Genomic Markers of Pathological Stage in Oral Squamous Cell Carcinoma.

Su Kyung KukJae Il LeeKi Tae Kim

Published in: Head and neck pathology (2022)

The genetic mutation type and ratio of tumor heterogeneity are different for each stage of OSCC, and stratification of OSCC patients with differential therapeutic efficacy is needed. Risk genes of both high and low stages must be identified in patients diagnosed with low-stage OSCC. Mutations in NOMO1, ZNF333, and WIZ should be considered as potential prognostic markers.

Keyphrases

end stage renal disease
genome wide
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
copy number
dna methylation
gene expression
climate change
transcription factor
patient reported